Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;15(1):79-86.
doi: 10.1007/s11307-012-0561-3.

Imaging of protein synthesis: in vitro and in vivo evaluation of (44)Sc-DOTA-puromycin

Affiliations

Imaging of protein synthesis: in vitro and in vivo evaluation of (44)Sc-DOTA-puromycin

Sebastian Eigner et al. Mol Imaging Biol. 2013 Feb.

Abstract

Purpose: The purpose of this study was to investigate whether (44)Sc-labeled puromycin can be utilized for imaging of protein synthesis in vivo.

Methods: For micro-positron emission tomographic (μPET) studies, 20-25 MBq of [(44)Sc]-DOTA-puromycin was administered to tumor-bearing rats, and animals were scanned for 1 h dynamically. Results were further validated by dissecting organs and tissues of the animals after the measurement and in vitro blocking experiments using puromycin or cycloheximide to block protein synthesis.

Results: μPET images of tumor-bearing rats showed significant tumor uptake of [(44)Sc]-DOTA-puromycin and a clear-cut tumor visualization. In both blocking experiments, cellular uptake of [(44)Sc]-DOTA-puromycin ([(44)Sc]-DOTA-Pur) could be suppressed by blocking protein synthesis.

Conclusions: We report for the first time successful μPET imaging with (44)Sc obtained from a (44)Ti/(44)Sc generator, as well as noninvasive μPET imaging of ribosomal activity, respectively protein synthesis, with a puromycin-based radiopharmaceutical and the direct correlation between cellular uptake of [(44)Sc]-DOTA-Pur and protein synthesis.

PubMed Disclaimer

References

    1. Radiother Oncol. 2010 Sep;96(3):280-7 - PubMed
    1. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1097-104 - PubMed
    1. J Nucl Med. 1994 Feb;35(2):317-25 - PubMed
    1. FEBS Lett. 1999 Nov 26;462(1-2):43-6 - PubMed
    1. J Nucl Med. 2004 Feb;45(2):347-55 - PubMed

MeSH terms

LinkOut - more resources